Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Correction to: Gsα deficiency in macrophages promotes tumor progression via the MAPK signaling pathway.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: April 21, 2026
18F-FDOPA PET/CT for neuroendocrine tumors in multiple endocrine neoplasia type 1.
Journal: Frontiers in endocrinology
Published: April 07, 2026
Expansion of Germline Variants in Primary Hyperparathyroidism: Fumarate Hydratase Deficiency as a Cause of Parathyroid Adenomas.
Journal: Endocrine pathology
Published: January 27, 2026
Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1.
Journal: Journal of neuroendocrinology
Published: December 14, 2025
Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 30, 2025
MEN1-Related Neuroendocrine Tumors Show c-MET Overexpression.
Journal: Journal of the Endocrine Society
Published: May 28, 2025
Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes.
Journal: Science (New York, N.Y.)
Published: February 06, 2025
Gsα deficiency in macrophages promotes tumor progression via the MAPK signaling pathway.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 06, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1.
Journal: Cancer letters
Published: November 23, 2024
Endothelial Gsα deficiency promotes ferroptosis and exacerbates atherosclerosis in apolipoprotein E-deficient mice via the inhibition of NRF2 signaling.
Journal: Acta pharmacologica Sinica
Published: August 20, 2024
Last Updated: 09/26/2026